The CD95/CD95L signaling pathway: A role in carcinogenesis. - Université de Rennes Access content directly
Journal Articles BBA - Biochimica et Biophysica Acta Year : 2014

The CD95/CD95L signaling pathway: A role in carcinogenesis.


Apoptosis is a fundamental process that contributes to tissue homeostasis, immune responses, and development. The receptor CD95, also called Fas, is a member of the tumor necrosis factor receptor (TNF-R) superfamily. Its cognate ligand, CD95L, is implicated in immune homeostasis and immune surveillance, and various lineages of malignant cells exhibit loss-of-function mutations in this pathway; therefore, CD95 was initially classified as a tumor suppressor gene. However, more recent data indicate that in different pathophysiological contexts, this receptor can transmit non-apoptotic signals, promote inflammation, and contribute to carcinogenesis. A comparison with the initial molecular events of the TNF-R signaling pathway leading to non-apoptotic, apoptotic, and necrotic pathways reveals that CD95 is probably using different molecular mechanisms to transmit its non-apoptotic signals (NF-κB, MAPK, and PI3K). As discussed in this review, the molecular process by which the receptor switches from an apoptotic function to an inflammatory role is unknown. More importantly, the biological functions of these signals remain elusive.
Fichier principal
Vignette du fichier
BBAreviewsoncancer-legembre-final.pdf (510.04 Ko) Télécharger le fichier
Origin : Files produced by the author(s)

Dates and versions

hal-01061290 , version 1 (05-09-2014)



Amélie Fouqué, Laure Debure, Patrick Legembre. The CD95/CD95L signaling pathway: A role in carcinogenesis.. BBA - Biochimica et Biophysica Acta, 2014, 1846 (1), pp.130-141. ⟨10.1016/j.bbcan.2014.04.007⟩. ⟨hal-01061290⟩
448 View
881 Download



Gmail Facebook X LinkedIn More